NRx Pharmaceuticals, Inc (NASDAQ:NRXP) is among the best psychedelic stocks to buy in 2026. NRx Pharmaceuticals, Inc ...
As of Monday, March 16, NRx Pharmaceuticals, Inc.’s NRXP share price has surged by 13.44%, which has investors questioning if ...
Zacks Investment Research on MSN
NRx Pharmaceuticals, Inc. (NRXP) surpasses Q4 earnings estimates
NRx Pharmaceuticals, Inc. (NRXP) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of ...
NRx Pharmaceuticals NRXP is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for NRXP’s loss per share is pinned at 20 cents. In the absence of a marketed product, ...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx”, the “Company”, “we”, “us” or “our”) announces the filing of its Form 10-K ...
NRx Pharmaceuticals (NASDAQ:NRXP) stock rallied 35% Monday after its subsidiary HOPE Therapeutics announced the signing of a binding term sheet with Smith & Sauer for $25M in equity purchases to fund ...
On Match 21st NRXP announced the results of a Special Meeting of Shareholders giving the Board of Directors authority to effect a reverse stock split of all of the outstanding shares of NRXP stock in ...
On Match 21st NRXP announced the results of a Special Meeting of Shareholders giving the Board of Directors authority to effect a reverse stock split of all of the outstanding shares of NRXP stock in ...
NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company developing therapeutics based on its NMDA platform for the treatment of central nervous system disorders, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results